EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Temporal Association Between COVID ‐19 Vaccination and HBsAg Loss in Chronic Hepatitis B Infection: An Interrupted Time Series Analysis

Jonggi Choi, Allison Carroll, Vy H Nguyen, Megan Michta, Xuan Q Zhang, Young-Suk Lim iD, Raymond T Chung

Alimentary Pharmacology & Therapeutics · 2026

DOI: 10.1111/apt.70733 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, 2026. Written by Jonggi Choi and 6 co-authors. Institution: Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Major MEDLINE topics: Hepatitis B, Chronic, Hepatitis B Surface Antigens, COVID-19, COVID-19 Vaccines. Cited 3 times so far (Crossref); 27 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Aims Hepatitis B surface antigen (HBsAg) loss, a functional cure in chronic hepatitis (CHB), is rare. Temporal changes in HBsAg loss rates were evaluated in relation to COVID‐19 vaccination rollout in South Korea.

Methods

An interrupted time series (ITS) analysis was performed using electronic health records of 59,946 adults with CHB (2002–2025). Monthly HBsAg loss incidence rates were estimated using a competing risk framework. National COVID‐19 vaccination coverage was used as a surrogate for population‐level exposure. A three‐phase segmental regression model assessed changes before vaccination, during a predefined vaccination effect period (18 months following ≥ 80% of two‐dose coverage), and after this period. Hepatocellular carcinoma (HCC) incidence was analysed as a negative control.

Results

Over 382,509 person‐years, 2483 HBsAg loss events occurred. Pre‐vaccination rates were stable (0.11–0.80 per 100 person‐years). Following the COVID‐19 vaccination rollout, the incidence increased to 0.96 in 2021, peaking at 1.27 in 2022, before declining to 0.93 in 2024. In the ITS model, no baseline trend was observed ( p = 0.606). At the intervention point (November 2021), HBsAg loss rates increased significantly (incidence rate ratio; 1.56; 95% CI 1.26–1.93; p < 0.001). No significant slope change was observed during the vaccination period, while a negative slope change was observed post‐vaccination (coefficient −0.039 per month; p = 0.003). Findings were consistent across sensitivity and subgroup analyses. HCC incidence showed no significant changes.

Conclusion

COVID‐19 vaccination was temporally associated with transiently higher HBsAg loss rates in CHB, followed by attenuation, suggesting a potential population‐level immunomodulatory effect on HBV dynamics.

Subjects

MeSH terms (MEDLINE)

Hepatitis B, ChronicHepatitis B Surface AntigensCOVID-19COVID-19 VaccinesHumansRepublic of KoreaFemaleMaleMiddle AgedInterrupted Time Series AnalysisAdultIncidenceVaccinationAgedCarcinoma, HepatocellularLiver Neoplasms

Author keywords

COVID‐19chronic hepatitis Bhepatitis B surface antigen

Substances

Hepatitis B Surface AntigensCOVID-19 Vaccines

Authors and institutions

  • Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Liver Center, Gastroenterology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Family Medicine, Newton-Wellesley Hospital, Newton, Massachusetts, USA.

ORCID profiles: Young-Suk Lim

Funding

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Choi, J., Carroll, A., Nguyen, V. H., Michta, M., Zhang, X. Q., Lim, Y. S., & Chung, R. T. (2026). Temporal Association Between COVID ‐19 Vaccination and HBsAg Loss in Chronic Hepatitis B Infection: An Interrupted Time Series Analysis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70733

Vancouver

Choi J, Carroll A, Nguyen VH, Michta M, Zhang XQ, Lim YS, et al. Temporal Association Between COVID ‐19 Vaccination and HBsAg Loss in Chronic Hepatitis B Infection: An Interrupted Time Series Analysis. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70733

BibTeX
@article{Choi2026,
  author = {Choi, Jonggi and Carroll, Allison and Nguyen, Vy H and Michta, Megan and Zhang, Xuan Q and Lim, Young-Suk and Chung, Raymond T},
  title = {Temporal Association Between COVID ‐19 Vaccination and HBsAg Loss in Chronic Hepatitis B Infection: An Interrupted Time Series Analysis},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.70733}
}
Start for free →